We are excited to announce a strategic AI partnership with BioSymetrics to develop treatment-predictive algorithms based on patient outcomes collected from over 15,000 patients tested with the Autoimmune Brain Panel. Our goal is to utilize this data to develop algorithms that can predict the most effective treatments for patients suffering from autoimmune-induced neuropsychiatric disorders. We believe that in the near future, medicine will move away from the trial-and-error paradigm towards precision and personalized medicine to more rapidly and effectively treat patients suffering from these chronic conditions. https://lnkd.in/eei-wDuX #precisionpsychiatry #neuropsychiatric #precisionmedicine
Moleculera Biosciences
Biotechnology
Oklahoma City, Oklahoma 511 followers
A Precision Medicine Company.
About us
Moleculera Biosciences offers advanced testing services in a fully-accredited CLIA/COLA clinical laboratory specializing in autoimmune neurobiology. As pioneers focusing on neuropsychiatric disorders caused by molecular mimicry, we offer the Autoimmune Brain Panel™, an aid to a physician’s diagnosis of autoimmune-based neuropsychiatric disorders. The Autoimmune Brain Panel™ helps identify whether an individual’s neurologic/psychiatric symptoms, such as obsessive compulsive behaviors, tics, anxiety, attention deficit hyperactivity disorder, and sometimes behaviors associated with Autism Spectrum Disorders, could be caused by a treatable autoimmune condition triggered by common infections.
- Website
-
http://www.moleculera.com
External link for Moleculera Biosciences
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Oklahoma City, Oklahoma
- Type
- Privately Held
- Founded
- 2011
- Specialties
- Immunology, Lyme Disease, Autoimmune Encephalopathy, PANDAS/PANS, and Neuropsychiatric Illness
Locations
-
Primary
Get directions
755 Research Pkwy
Suite 410
Oklahoma City, Oklahoma 73104, US
Employees at Moleculera Biosciences
Updates
-
We were honored to present and participate at this year's Mast Cell Masterminds Conference! Thanks to the committee for putting together such an informative conference! #mastcell #neuropsychiatric
-
-
We are excited about the opportunity we have to impact the lives of those suffering from immune-mediated neuropsychiatric and behavioral disorders!
I'm relieved that I DON'T play basketball! But I was honored to share the same podium with these notable pioneers as they shared about making a difference in the lives of others. It was illuminating to hear from William Shatner with his stories about the "Tricorder" in context with the incredible future of medical technology. It was also inspiring to hear from Metta World Peace about his transformation into a true impact-investing businessperson, and the tenacious steps he took as an entrepreneur to build a global business enterprise from scratch. Thank you Neil Greene, for the opportunity to share our story about Moleculera Biosciences to all the impact-investors at your Jaboy conference in Beverly Hills! I look forward to the many follow-up meetings with those who have expressed significant interest in our mission and vision! #entrepreneurship #lifescience #biotechnology
-
-
We are thrilled to announce the appointment of Asad Hussain to our Board as Strategic Finance Advisor! Asad brings a wealth of experience as a seasoned institutional investor and growth strategist for large, publicly-traded, multi-national institutions and private companies. He has led strategic M&A transactions of over $12 billion across financial services, technology, and life sciences verticals. "Mr. Hussain’s deep understanding of financial strategy and proven track record in delivering value makes him a perfect fit for our company as we continue to accelerate our growth objectives,” said Dr. Craig Shimasaki.
Moleculera Biosciences welcomes Asad Hussain as Board Advisor on Strategic Finance
einnews.com
-
We are excited to welcome Robert Mozayeni, MD to our Medical and Clinical Advisor Board! Dr. Mozayeni is an accomplished physician, researcher, and leader in the fields of infectious disease and immune-mediated responses.
Moleculera Biosciences Names B. Robert Mozayeni, MD as Medical and Clinical Advisor
einnews.com
-
Dr. Shimasaki shares the case of a 16-year-old girl who developed severe OCD at age 11 due to an infection-triggered autoimmune response. Testing with the Autoimmune Brain Panel helped identify the underlying immune-mediated root cause of her psychiatric symptoms. Full presentation: https://lnkd.in/esnhbk5N
-
Moleculera has completed an extensive rebranding initiative to reflect the company's expanded scope of research and product offerings, including additional autoantibody tests in development for chronic CNS and cardiovascular disorders driven by inflammation and immune dysfunction. Our new name, Moleculera Biosciences signifies our renewed commitment to advancing precision medicine with innovative molecular testing panels, a robust biorepository of immune-mediated specimens, biomarker discovery, and novel therapeutic target identification. #autoantibody #precisionmedicine #neuropsychiatric https://lnkd.in/ejC5n4p9
Moleculera Labs announces rebrand to Moleculera Biosciences as company expands into new sectors
einnews.com
-
We are excited to welcome Dr. Safedin Sajo Beqaj as Clinical Laboratory Advisor. Dr. Beqaj brings vast experience and expertise in areas of medical research, laboratory operations, teaching, molecular diagnostics and business management to the Company’s Scientific and Clinical Board of Advisors. His insights and strategic support will be invaluable as we continue to expand the clinical scope of our work for immune-mediated CNS and cardiovascular disorders. https://lnkd.in/e8uwQC54
Moleculera Biosciences Names Dr. Safedin Sajo Beqaj as Clinical Laboratory Advisor
einnews.com
-
Join us for a July Networking Event! On July 11th, we will host a networking event that includes a tour of #ConvergenceOKC, Oklahoma’s newest mixed-use industry and life science complex designed to support technology industry growth in the heart of #OKCInnovationDistrict. Convergence is home to Innovation Hall, which includes #BioTC, a bio-manufacturing workforce training center. Please RSVP here so we can have a headcount! https://lnkd.in/g-uSPPr8
This content isn’t available here
Access this content and more in the LinkedIn app
-
Join us at the Greater Oklahoma City Chamber Forum to hear of the exciting advances in the bioscience industry in Oklahoma!
Our bioscience industry is thriving and continues to grow rapidly thanks to the $35 million Build Back Better grant awarded in September 2022. The Greater Oklahoma City Chamber is hosting a forum with the latest industry updates, learn about new program developments, hear details on a re-formed statewide organization, and celebrate successes from the BIO International Convention! 🔗 Online registration closes June 14. Register now! https://lnkd.in/gwW_pGFh Don’t miss this chance to connect with industry leaders and stay informed about the exciting advancements in our bioscience community! 🌟 Panelist Inlcude: Craig Shimasaki , Stephanie Wickham, Christian Kanady, Rachel Lane PhD, RD Thanks to: Echo, Cytovance Biologics, Moleculera Biosciences and University of Oklahoma - Price College of Business #OKCInnovation #Bioscience #BuildBackBetter #BIO2024 #ChamberForum
-